These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2077083)

  • 1. [Principles of cancer chemotherapy].
    Fukushima M
    Nihon Seikeigeka Gakkai Zasshi; 1990 Dec; 64(12):1249-58. PubMed ID: 2077083
    [No Abstract]   [Full Text] [Related]  

  • 2. Response surface methodology and the design of clinical trials for the evaluation of cancer chemotherapy.
    Carter WH
    Cancer Treat Rep; 1985 Oct; 69(10):1049-53. PubMed ID: 4042084
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant/primary chemotherapy in cancer treatment: what advantage?
    Wynendaele W; van Oosterom AT
    Forum (Genova); 1999; 9(3):212-21. PubMed ID: 10504169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scientific basis of clinical trials: statistical aspects.
    Gehan EA
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-analysis of randomized clinical trials in cancer.
    Buyse M
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2501-6. PubMed ID: 8279848
    [No Abstract]   [Full Text] [Related]  

  • 6. Curative cancer chemotherapy.
    Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer clinical trials: the emergence and development of a new style of practice.
    Keating P; Cambrosio A
    Bull Hist Med; 2007; 81(1):197-223. PubMed ID: 17369668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy in osteosarcoma. Basis for application and antagonism to implementation; early controversies surrounding its implementation.
    Jaffe N; Patel SR; Benjamin RS
    Hematol Oncol Clin North Am; 1995 Aug; 9(4):825-40. PubMed ID: 7490244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factorial designs for randomized clinical trials.
    Byar DP; Piantadosi S
    Cancer Treat Rep; 1985 Oct; 69(10):1055-63. PubMed ID: 4042085
    [No Abstract]   [Full Text] [Related]  

  • 10. [Chemotherapy of osteosarcomas].
    Kalifa C; Rubie H; Lemerle J
    Chir Pediatr; 1985; 26(4):233-7. PubMed ID: 3907873
    [No Abstract]   [Full Text] [Related]  

  • 11. An efficient design for phase III studies of combination chemotherapies.
    Ellenberg SS; Eisenberger MA
    Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutics: clinical trials--a review of terms and principles: part I.
    Reich SD
    Cancer Nurs; 1982 Jun; 5(3):232-3. PubMed ID: 6919461
    [No Abstract]   [Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: a comparison of results obtained in single-institution and multicenter trials.
    Bacci G; Mercuri M; Longhi A; Setola E; Gozzi E; Forni C
    Chir Organi Mov; 2004; 89(4):283-92. PubMed ID: 16048049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical research: definition and principles].
    Jovic L
    Rech Soins Infirm; 1997 Mar; (48):40-6. PubMed ID: 9287285
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
    Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
    Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of measurement error on response rates.
    Warr D; McKinney S; Tannock I
    Cancer Treat Rep; 1985 Oct; 69(10):1127-32. PubMed ID: 4042092
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant therapy in the treatment of osteosarcoma.
    Link MP
    Important Adv Oncol; 1986; ():193-207. PubMed ID: 3330533
    [No Abstract]   [Full Text] [Related]  

  • 18. Human models for cancer active immunotherapy.
    Mathé G
    Biomedicine; 1977 Feb; 26(1):1-5. PubMed ID: 324528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleomycin, cyclophosphamide, and dactinomycin in metastatic osteosarcoma: lack of tumor regression in previously treated patients.
    Pratt CB; Epelman S; Jaffe N
    Cancer Treat Rep; 1987 Apr; 71(4):421-3. PubMed ID: 2435408
    [No Abstract]   [Full Text] [Related]  

  • 20. Bypassing phase 1 trials in the cancer drug development paradigm: generally unwise and potentially dangerous.
    Markman M
    Cancer; 2010 Nov; 116(22):5116-8. PubMed ID: 20665504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.